The Latest Cardiac and Vascular News
Company continued to launch new products, win share, and deliver strong earnings growth; market procedure volumes impacted by COVID-19 resurgence DUBLIN, Nov. 23, 2021 /PRNewswire(opens new window)/ — Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2022, which ended October 29, 2021. Key Highlights Revenue of $7.8 billion increased […]
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN). “This is an important and strategic opportunity for our company to continue growing our cardiovascular portfolio and pipeline, that builds on our […]
HOOFDDORP, The Netherlands–(BUSINESS WIRE)–OMRON Healthcare Europe announced that David Menko has been appointed as the company’s President and Chief Executive Officer effective December 1st. David Menko succeeds André van Gils who steps down as CEO for Europe and will continue to lead the global organization in his role of Senior […]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, today announced changes to its Board of Directors including the addition of June Lee, M.D., and the transition of JJ Kang, […]
MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)–PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the appointment of Jonathan J. Birchall as Chief Commercial Officer. “Jonathan brings to PhaseBio deep commercial expertise in the critical-care setting, which he […]
– Revenues Increased 23% Year-over-Year to $13.6 Million – – U.S. WatchPAT™ Revenues Increased 27% Year-over-Year to $11.3 Million – CAESAREA, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported unaudited financial results […]
CAESAREA, Israel, Nov. 18, 2021 /PRNewswire/ — Filterlex Medical, a cardiovascular medical device startup, announced today that it has recently completed a US $6 Million series A1 investment round from leading private healthcare investors. The financing will accelerate implementation of the company’s CAPTIS® clinical program. The CAPTIS is a next-generation, full-body embolic protection device to reduce […]
ENGLEWOOD, Colo., Nov. 18, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced it has been ranked 7th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte’s 2021 […]
DURHAM, N.C., Nov. 18, 2021 (GLOBE NEWSWIRE) — Aerami Therapeutics, Inc. (the “Company”), a leader in the field of developing inhaled therapies to treat severe respiratory and chronic diseases, today announced the appointment of Barry Deutsch as chief financial officer effective November 15, 2021. “Barry is a seasoned financial executive who brings […]
SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, today announced the closing of its underwritten initial public offering of 2,750,000 units, each consisting of (i) one share of common stock and (ii) […]
